Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
We break down the top-performing altcoins over the past five years, spotlighting winners and the factors driving their returns for smarter investing.
25,048 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
NVIDIA is accelerating its on-device AI push, signaling a potential TAM expansion as edge computing moves from theory...
Authorities say Nancy Pelosi’s husband could face misdemeanor charges after a Napa wine country hit-and-run, which le...
Cathie Wood is back in the IPO spotlight. This piece breaks down the three newly public names Ark Invest reportedly a...
Dream Finders has offered cash to acquire Beazer at roughly $32 per share, elevating the stakes for both companies. T...
Amazon's AI hardware strategy could extend far beyond cloud services. This article explains how Trainium and Inferent...
Sandisk stock dropped again as memory-chip demand uncertainty echoed through the market. This guide breaks down why t...
ServiceNow could deliver durable growth as organizations automate more workflows. This article lays out the bull case...
Ford faces a turning point as it expands EV capabilities while navigating a volatile market. Here are three scenarios...
As markets wobble, tokenized real-world assets are expanding fast. Major exchanges like Coinbase, Kraken, and Binance...
Markets have celebrated a long rally, but chair nominee kevin warsh's real test may lie in credibility, independence,...
Even as oil prices swing widely, four energy dividend giants have kept their payouts steady and growing. This piece l...